BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29267269)

  • 1. Role of depression in secondary prevention of Chinese coronary heart disease patients receiving percutaneous coronary intervention.
    Feng C; Ji T; Liu Y; Chen D; Dai J; Ni X; Zhu J; Liu X; Zhao X
    PLoS One; 2017; 12(12):e0187016. PubMed ID: 29267269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of Secondary Prevention among Coronary Heart Disease Patients in a High-Risk Region in Finland.
    Repo T; Tykkyläinen M; Mustonen J; Rissanen TT; Ketonen M; Toivakka M; Laatikainen T
    Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29641497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Predictive Effect of Negative Psychological Emotions of Anxiety and Depression on the Poor Prognosis of CHD Patients with Stent Implantation and the Improvement of Clinical Intervention Measures.
    Li G; Tian Y; Zhang Q; Jin Z; Song Y
    Comput Math Methods Med; 2022; 2022():2534277. PubMed ID: 35136415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status of blood pressure control in patients with coronary heart disease].
    Zhang Y; Wang TT; Guo SL; Han LN; Zhang L; Li XY; Fan J
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):23-27. PubMed ID: 29926654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between patient's health literacy and adherence to coronary heart disease secondary prevention measures.
    Lu M; Ma J; Lin Y; Zhang X; Shen Y; Xia H
    J Clin Nurs; 2019 Aug; 28(15-16):2833-2843. PubMed ID: 30938879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: Results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) Project.
    Niu S; Zhao D; Zhu J; Liu J; Liu Q; Liu J; Wang W; Smith SC;
    Am Heart J; 2009 Apr; 157(4):709-15.e1. PubMed ID: 19332200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to Treatment of Female Patients With Coronary Heart Disease After a Percutaneous Coronary Intervention.
    Kähkönen O; Saaranen T; Kankkunen P; Miettinen H; Kyngäs H
    J Cardiovasc Nurs; 2019; 34(5):410-417. PubMed ID: 31365439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing return to work 3 months after percutaneous coronary intervention in young and middle-aged patients with coronary heart disease: A single-center, cross-sectional study.
    Hu Y; Zhou T; Li X; Chen X; Wang X; Xu J; Gu D
    PLoS One; 2023; 18(4):e0284100. PubMed ID: 37075024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient confidence regarding secondary lifestyle modification and knowledge of 'heart attack' symptoms following percutaneous revascularisation in Japan: a cross-sectional study.
    Kitakata H; Kohno T; Kohsaka S; Fujino J; Nakano N; Fukuoka R; Yuasa S; Maekawa Y; Fukuda K
    BMJ Open; 2018 Mar; 8(3):e019119. PubMed ID: 29549203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of uncontrolled cardiovascular risk factors in patients treated with percutaneous interventions for stable coronary artery disease not receiving cardiac rehabilitation.
    Khattab AA; Knecht M; Meier B; Windecker S; Schmid JP; Wilhelm M; Saner H
    Eur J Prev Cardiol; 2013 Oct; 20(5):743-9. PubMed ID: 22547410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensive nursing care by an electronic followup system to promote secondary prevention after percutaneous coronary intervention: a randomized trial.
    Hu X; Zhu X; Gao L
    J Cardiopulm Rehabil Prev; 2014; 34(6):396-405. PubMed ID: 24667664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The china patient-centered evaluative assessment of cardiac events (PEACE) prospective study of percutaneous coronary intervention: Study design.
    Du X; Pi Y; Dreyer RP; Li J; Li X; Downing NS; Li L; Feng F; Zhan L; Zhang H; Guan W; Xu X; Li SX; Lin Z; Masoudi FA; Spertus JA; Krumholz HM; Jiang L;
    Catheter Cardiovasc Interv; 2016 Dec; 88(7):E212-E221. PubMed ID: 26945565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective secondary prevention through cardiac rehabilitation after coronary revascularization and predictors of poor adherence to lifestyle modification and medication. Results of the ICAROS Survey.
    Griffo R; Ambrosetti M; Tramarin R; Fattirolli F; Temporelli PL; Vestri AR; De Feo S; Tavazzi L;
    Int J Cardiol; 2013 Aug; 167(4):1390-5. PubMed ID: 22575623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression and anxiety as predictors of recurrent cardiac events 12 months after percutaneous coronary interventions.
    Park JH; Tahk SJ; Bae SH
    J Cardiovasc Nurs; 2015; 30(4):351-9. PubMed ID: 24763357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The assessment of coronary heart disease risk factors correlated with demographic and social data in post-coronary intervention patients in Polish population.
    Budnik M; Opolski G
    Cardiol J; 2015; 22(3):276-84. PubMed ID: 26118382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-management in patients with coronary heart disease after stent implantation at the long-term stage: a cross-sectional study.
    Zhu H; Chen G; Xue X; Zheng S
    Ann Palliat Med; 2022 Jul; 11(7):2265-2274. PubMed ID: 35445603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Impact of Secondary Prevention Programs Incorporating Remote Technologies on Psychological Well-Being and Quality of Life in Coronary Heart Disease Patients with Abdominal Obesity].
    Pogosova NV; Salbieva AO; Sokolova OY; Ausheva AK; Karpova AV; Eganyan AA; Suvorov AY; Nikityuk DB; Drapkina OM
    Kardiologiia; 2019 Dec; 59(12):11-19. PubMed ID: 31849306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Knowledge Level of Coronary Heart Disease and Risk Factors Among Post-Percutaneous Coronary Intervention Patients Adequate?
    Nolan MT; McKee G
    J Cardiovasc Nurs; 2016; 31(3):E1-9. PubMed ID: 26422635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein (a) and coronary heart disease - is there an efficient secondary prevention?
    Mellwig KP; Horstkotte D; van Buuren F
    Clin Res Cardiol Suppl; 2017 Mar; 12(Suppl 1):18-21. PubMed ID: 28233270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.